EUVIMEDEUVIMED entdecken
Crossref

A bibliometric analysis of RNA methylation in prostate cancer and its complications from 2003 to 2024

Huifeng Wang, Xiangyuan Wei, Junjie Ye, Bo Xie, Junling Shan, Xiangfa Deng, Die Zhang, Lu Xu, Zengjing Liu, Nada M.A. Hassan, Chao Liu, Yu`ang Mao

iCell · 2024

DOI: 10.71373/lhki4844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift iCell, 2024. Verfasst von Huifeng Wang und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

RNA methylation has emerged as an active research field in prostate cancer (PCa) and its complications, while few bibliometric analyses have been performed. This study aims to analyze the development trends and hotspots of RNA methylation research to provide a comprehensive and objective overview of the current research status in this field of prostate cancer using bibliometric methods.

Methods

The articles and reviews regarding RNA methylation in PCa and its complications from 2003 to 2024, were retrieved from the Web of Science Core Collection databases. A retrospective bibliometric analysis and science mapping were performed using the CiteSpace software, the VOSviewer software, and the R package “bibliometrix” to plot the knowledge maps and predict the hotspots and trends.

Results

One hundred and twenty-two qualified records were retrieved. The annual publications gradually increased over the past 22 years. These publications mainly came from 19 countries led by China and 138 institutions. Among top 10 funders, 8 were Chinese, with NSFC supporting 68 studies. The most common keywords were “prostate cancer”, “expression”, “messenger-RNA”, “progression”, “methyltransferase METTL3 promotes”, “N6-methyladenosine”, and “promotes”. Keyword trends shifted from “m6A, METTL3” to “m6A modification, androgen receptor, metastasis”. N6-methyladenosine (m6A) within prostate cancer and its associated complications is an emerging frontier, with “m6A score” and “cellular senescence” as current priorities.

Conclusion

This research represents the inaugural bibliometric examination of the application of RNA methylation in PCa, utilizing three acknowledged bibliometric tools. It offers an impartial overview and holistic direction for subsequent pertinent studies.

Zitieren

APA

Wang, H., Wei, X., Ye, J., Xie, B., Shan, J., Deng, X., Zhang, D., Xu, L., Liu, Z., Hassan, N. M., Liu, C., & Mao, Y. (2024). A bibliometric analysis of RNA methylation in prostate cancer and its complications from 2003 to 2024. iCell. https://doi.org/10.71373/lhki4844

Vancouver

Wang H, Wei X, Ye J, Xie B, Shan J, Deng X, et al. A bibliometric analysis of RNA methylation in prostate cancer and its complications from 2003 to 2024. iCell. 2024. doi:10.71373/lhki4844

BibTeX
@article{Wang2024,
  author = {Wang, Huifeng and Wei, Xiangyuan and Ye, Junjie and Xie, Bo and Shan, Junling and Deng, Xiangfa and Zhang, Die and Xu, Lu and Liu, Zengjing and Hassan, Nada M.A. and Liu, Chao and Mao, Yu`ang},
  title = {A bibliometric analysis of RNA methylation in prostate cancer and its complications from 2003 to 2024},
  journal = {iCell},
  year = {2024},
  doi = {10.71373/lhki4844}
}
Kostenlos starten →